FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

387050005: Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3753010015 Prostaglandin-endoperoxide synthase isoform 2 inhibitor en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3753726011 Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3753727019 COX-2 inhibitor en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core
3753728012 PTGS-2 inhibitor en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core
3753729016 Cyclooxygenase-2 inhibitor en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
1461228011 Cox-2 inhibitor (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1461228011 Cox-2 inhibitor (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1481164012 Cox-2 inhibitor en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1481164012 Cox-2 inhibitor en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
1491847014 Inhibitor of cyclooxygenase-2 en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1491847014 Inhibitor of cyclooxygenase-2 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3520723015 Substance with cyclooxygenase-2 inhibitor mechanism of action (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3520894010 Substance with cyclooxygenase-2 inhibitor mechanism of action en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3753010015 Prostaglandin-endoperoxide synthase isoform 2 inhibitor en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3753726011 Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3753727019 COX-2 inhibitor en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core
3753728012 PTGS-2 inhibitor en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core
3753729016 Cyclooxygenase-2 inhibitor en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
400601000274116 COX-2-Inhibitoren de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
400601000274116 COX-2-Inhibitoren de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


29 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) Is a Non-steroidal anti-inflammatory agent true Inferred relationship Existential restriction modifier (core metadata concept)
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) Is a Enzyme inhibitor false Inferred relationship Existential restriction modifier (core metadata concept)
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) Has disposition Cyclooxygenase-2 inhibitor true Inferred relationship Existential restriction modifier (core metadata concept)
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) Is a Substance with prostaglandin-endoperoxide synthase inhibitor mechanism of action (substance) true Inferred relationship Existential restriction modifier (core metadata concept)

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing etodolac (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) Inferred relationship Existential restriction modifier (core metadata concept)
COX-2 inhibitor-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely etodolac 200 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Etodolac 300mg capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Etodolac 600mg m/r tablet (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Celecoxib 200 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely celecoxib 100 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Celecoxib-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Etodolac 500mg m/r tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Etodolac 400mg m/r tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely etodolac 400 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Etodolac 500 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing valdecoxib (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Valdecoxib 10 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely valdecoxib 20 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Nabumetone (substance) Is a True Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Rofecoxib (substance) Is a True Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Meloxicam (substance) Is a True Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Parecoxib-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Parecoxib 40mg injection (pdr for recon) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Parecoxib 40mg injection (pdr for recon)+diluent The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Etoricoxib-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Etoricoxib 60mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Etoricoxib 90mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Etoricoxib 120mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Etoricoxib 60 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Etoricoxib 90 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Etoricoxib 120 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Parecoxib 40mg injection (pdr for recon) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Parecoxib 40mg injection (pdr for recon)+diluent The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Valdecoxib 40 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Celecoxib Is a True Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Etoricoxib (substance) Is a True Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Parecoxib (substance) Is a True Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Valdecoxib (substance) Is a True Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Deracoxib Is a True Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Firocoxib Is a True Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Lumiracoxib (substance) Is a True Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Nimesulide (substance) Is a True Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Parecoxib sodium (substance) Is a True Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Ketorolac tromethamine Is a True Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Ketorolac Is a True Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Etodolac (substance) Is a True Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Nepafenac (substance) Is a True Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Ibuprofen sodium Is a True Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Ibuprofen (substance) Is a True Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Ibuprofen sodium dihydrate (substance) Is a True Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Ibuprofen lysine (substance) Is a True Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Dexibuprofen Is a True Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Dexketoprofen trometamol (substance) Is a True Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Dexketoprofen (substance) Is a True Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Naproxen sodium (substance) Is a True Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Naproxen (substance) Is a True Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Fenoprofen Is a True Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Fenoprofen calcium Is a True Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Alminoprofen Is a True Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Polmacoxib Is a True Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) Inferred relationship Existential restriction modifier (core metadata concept)

This concept is not in any reference sets

Back to Start